One Dead, Four Hurt in London Crane Collapse

first_imgAll contents © copyright 2020 The Associated Press. All rights reserved. The scene in Bow where a 20-metre crane collapsed on to a property leaving people trapped inside, in east London, Wednesday July 8, 2020. The London Fire Brigade says a 20-meter crane has collapsed onto a block of apartments under development and two houses in east London. The brigade’s Assistant Commissioner Graham Ellis says urban search and rescue crews are undertaking “a complex rescue operation” and using specialized equipment to search the properties on Wednesday. (Dominic Lipinski/PA via AP) The scene in Bow where a 20-metre crane collapsed on to a property leaving people trapped inside, in east London, Wednesday July 8, 2020. The London Fire Brigade says a 20-meter crane has collapsed onto a block of apartments under development and two houses in east London. The brigade’s Assistant Commissioner Graham Ellis says urban search and rescue crews are undertaking “a complex rescue operation” and using specialized equipment to search the properties on Wednesday. (Dominic Lipinski/PA via AP) 65-foot crane down on block of apartments “Sadly, despite the efforts of emergency services, a fifth person has been found and died at the scene,” the London Ambulance Service said. Four people were treated, including two people taken to the hospital with head injuries. Crews and a team of specialist paramedics who work in hazardous environments were at the scene in the Bow neighborhood. “This is a multi-agency response and is likely to be a protracted incident,” Ellis said. London Fire Brigade Assistant Commissioner Graham Ellis said search-and-rescue crews were using specialized equipment to search the properties as part of “a complex rescue operation” on Wednesday afternoon. The scene in Bow where a 20-metre crane collapsed on to a property leaving people trapped inside, in east London, Wednesday July 8, 2020. The London Fire Brigade says a 20-meter crane has collapsed onto a block of apartments under development and two houses in east London. The brigade’s Assistant Commissioner Graham Ellis says urban search and rescue crews are undertaking “a complex rescue operation” and using specialized equipment to search the properties on Wednesday. (Victoria Jones/PA via AP) LONDON (AP) – A 20-meter (65-foot) crane collapsed onto a block of apartments under development and two houses in east London, killing one person and injuring four others, authorities said Wednesday. Emergency personnel at the scene in Bow where a 20-metre crane collapsed on to a property leaving people trapped inside, in east London, Wednesday July 8, 2020. The London Fire Brigade says a 20-meter crane has collapsed onto a block of apartments under development and two houses in east London. The brigade’s Assistant Commissioner Graham Ellis says urban search and rescue crews are undertaking “a complex rescue operation” and using specialized equipment to search the properties on Wednesday. (Victoria Jones/PA via AP)last_img read more

Biologists Risk Their Lives to Find Hiding Place of Extinct ‘Tree Lobster’

first_imgAddThis Sharing ButtonsShare to FacebookFacebookFacebookShare to TwitterTwitterTwitterShare to EmailEmailEmailShare to RedditRedditRedditShare to MoreAddThisMore AddThis Sharing ButtonsShare to FacebookFacebookFacebookShare to TwitterTwitterTwitterShare to EmailEmailEmailShare to RedditRedditRedditShare to MoreAddThisMore“Ball’s Pyramid” is a sheer rock cliff in the middle of the South Pacific Ocean. For years this leftover shard of a volcano had a secret.At 225 feet above sea level, hanging on the rock surface, there is a small, spindly little bush, and under that bush, a few years ago, two climbers, working in the dark, found something totally improbable hiding in the soil below. How it got there, we still don’t know, writes NPR’s Robert Krulwich.The stick insect — as big as a human hand and called a “tree lobster” because of its hard, lobster-like exoskeleton — disappeared from a nearby island, its only known habitat, after a European ship wrecked there and left rats that wiped out their population.The Lord Howe stick insect, Dryococelus australis, was presumed extinct. There was a rumor though….(READ the story from NPR)Photo by Nick Carlile, inset, John White Photographylast_img read more

South Pacific Stars Danny Burstein and Paulo Szot Reunite for the Metropolitan Opera’s Die Fledermaus

first_imgFour-time Tony nominee Danny Burstein is heading to the opera—the Metropolitan Opera, that is. Burstein will make his Met debut on New Year’s Eve in the non-singing role of Frosch, the jailer, in Die Fledermaus alongside his former South Pacific co-star Paulo Szot as Dr. Falke. This all-new production of Johann Strauss II’s classic features English-language lyrics by Jeremy Sams and dialogue by Tony nominee Douglas Carter Beane. Directed by Sams and conducted by Adam Fischer, Die Fledermaus runs December 31 through February 22. Related Shows Burstein most recently appeared onstage in Encores!’ The Cradle Will Rock and in the acclaimed off-Broadway revival of Talley’s Folly. He has been nominated for Tony Awards for his performances in Follies, Golden Boy, The Drowsy Chaperone and South Pacific. A renowned Brazilian opera singer and four-time veteran of the Metropolitan Opera, Szot won a Tony Award for his Broadway debut as Emile De Becque in South Pacific. In addition to Burstein and Szot, Sams’ production will feature Susanna Phillips as Rosalinde, Christine Schäfer and Jane Archibald as Adele, Anthony Roth Costanzo as Orlofsky, Christopher Maltman as Eisenstein, Michael Fabiano as Alfred and Patrick Carfizzi as Frank. View Comments Metropolitan Opera: Die Fledermauscenter_img Star Files Die Fledermaus is a farce about jail, a grand ball and mistaken identities. Show Closed This production ended its run on Jan. 7, 2016 Danny Bursteinlast_img read more

Next hurdle for Mission Gateway plan is city council vote later this month

first_imgThe Gateway propertyThe next hurdle for the Mission Gateway plan will come later this month when the city council considers a preliminary site plan recently passed by the Mission Planning Commission.The latest proposal is similar to one that was approved by the council in January, but adds 74 market rate apartments above the 155,000 square foot Walmart store that anchors the east end of the development.Mayor Steve Schowengerdt broke a 4-4 council tie to approve the last plan which also had retail, a hotel, apartments and a potential office building. But since that vote, a city election brought three new members to the city council, which has the potential to change the outcome. The plan will come to the council at its Aug. 17 meeting.If the preliminary site plan gets council approval on Aug. 17, the city council has tentatively scheduled work sessions on Aug. 24 and Aug. 31. Those work sessions would be dedicated to other aspects of the Gateway plan such as the development agreement and any public participation in financing. Both would require council approval.Previous Gateway development proposals have included requests for Tax Increment Financing (TIF) and Community Improvement Districts (CID) that would collect increases in property tax and additional sales tax at the site to offset construction costs. The council already has held one work session to brief council members on the public financing intricacies.last_img read more

McCarville breaks hand bone in practice

first_imgMcCarville breaks hand bone in practice Aaron BlakeOctober 29, 2004Jump to CommentsShare on FacebookShare on TwitterShare via EmailPrintMinnesota’s women’s basketball team will be without Big Ten Preseason Player of the Year Janel McCarville for up to four weeks after the senior broke the third metacarpal bone in her left hand in practice Thursday.Coach Pam Borton said McCarville was participating in one of the Gophers’ usual drills when she lost her footing and caught her fall in an awkward manner.Borton said the four-week time frame appeared to be “a conservative estimate” after an initial evaluation. A second evaluation will take place today to confirm the injury.“You never want any of your kids to get injured, but that’s just the nature of the sport,” Borton said. “It might as well be before the Big Ten season or any of the important games.”McCarville’s setback comes just more than two weeks before the Gophers begin their regular season Nov. 14 at the WBCA Classic in Seattle. The four-week estimate means she could return by the time the Gophers hold the Subway Classic on Nov. 19 – Nov. 20 at Williams Arena. The third metacarpal bone is between the middle finger knuckle and the wrist in the middle of the hand.Lindsay Whalen led the Gophers to the Final Four last season after breaking the same bone – along with the fourth metacarpal bone in her right hand – in Columbus, Ohio, against Ohio State on Feb. 12.Whalen was healthy enough to return for the first round of the NCAA Tournament on March 21.In that tournament, McCarville set an NCAA record with 75 rebounds in five games, leading up to a national semifinal loss to Connecticut.“We’ve been in this situation before, which is a positive thing,” Borton said. “Other people will step up and make us better.”last_img read more

Live debate airs major divisions in H5N1 research battle

first_imgFeb 3, 2012 (CIDRAP News) – The controversy over research about potentially dangerous H5N1 viruses heated up last night in a New York City debate that featured some of the leading voices exchanging blunt comments on the alleged risks and benefits of publishing or withholding the full details of the studies.The debate, sponsored by the New York Academy of Sciences, involved two members of the biosecurity advisory board that called for “redacting” the two studies in question to delete details, along with scientists who want the full studies published and representatives of Science and Nature, the two journals involved.The 2-hour session, which was live-streamed on the Web, left no clear impression of how the current controversy or future dilemmas over conduct and publication of “dual use” research might be resolved. One of very few points on which the panelists were unanimous was the hope that the current battle won’t be repeated.”I hope that this redaction, which I do feel has some very valuable things associated with it, is a onetime event,” said Barbara Jasny, PhD, deputy editor for commentary at Science. “I hope this is not something that’ll become institutionalized as a way of dealing with the problem.”The two studies involved the generation of an H5N1 virus and an H5N1-H1N1 reassortant that spread among ferrets via respiratory droplets. In December the National Science Advisory Board for Biosecurity (NSABB), which advises the Department of Health and Human Services (HHS), recommended that the details be deleted from the two reports before they are published. HHS agreed and passed the recommendation to Science and Nature.The journals have signaled they will go along with the recommendation if a way can be found to provide the details of the reports to scientists with a legitimate need for them. But since the NSABB recommendation was unveiled, scientists, biosecurity experts, and public health officials have vigorously debated the issue in the media and in journal commentaries.Thursday’s discussion covered most or all of the main points of contention, including the magnitude of the H5N1 threat in general and the mutant viruses in particular, the reliability of ferrets as a model for human influenza, the potential public health benefits of the two studies, and government’s role in regulating scientific research.The study under review at Science was led by Ron Fouchier, PhD, of the Netherlands, whose team generated its transmissible H5N1 variant through a combination of genetic engineering and adaptation in ferrets. The study submitted to Nature was led by Yoshihiro Kawaoka of the University of Wisconsin, who created a virus that combined the hemagglutinin gene from an H5N1 virus with seven genes from a pandemic 2009 H1N1 virus. Fouchier’s virus is lethal in ferrets, but Kawaoka’s is not.Genesis of NSABB recommendationIn opening the discussion, Jasny said Science’s editors recognized early that Fouchier’s paper had biosecurity implications, so they convened a group of experts, including some NSABB members, for advice. At the same time, the National Institutes of Health, which funded the study, also brought the paper to the NSABB’s attention, she said.Michael T. Osterholm, PhD, MPH, an NSABB member, said the board set up a working group to consider the two manuscripts and brought in outside expert advisors, including Robert Webster,PhD, of St. Jude Children’s Hospital in Memphis and James Curran, MD, MPH, of Emory University. The working group spent “hundreds and hundreds of hours” discussing the problem, leading to unanimous support for the recommendation to withhold the details of the studies. Osterholm is director of the University of Minnesota’s Center for Infectious Disease Research and Policy, which publishes CIDRAP News.Arturo Casadevall, MD, PhD, the other NSABB member on the panel, said he initially thought the studies should be published in full, “but as a result of the deliberative process, I changed my mind.” He is a professor of microbiology and immunology at Albert Einstein College of Medicine in the Bronx, N.Y.When panel moderator Ian Lipkin, MD, later asked Casadevall if any other NSABB members changed their minds during the discussions, he declined comment other than to say there was a long deliberative process. Lipkin is a professor of epidemiology and of neurology and pathology at Columbia University.Both Osterholm and Casadevall emphasized they were speaking as individuals and not on behalf of the NSABB.Debate over case-fatality ratioMuch of the debate focused on questions related to how much of a threat the mutant viruses represent. That began early in the session, when Osterholm and Peter Palese, PhD, argued about the case-fatality ratio (CFR) for human H5N1 infections. Palese is a professor of microbiology and chair of the Department of Microbiology at Mount Sinai School of Medicine in New York City.The World Health Organization (WHO) lists 583 confirmed H5N1 cases with 344 deaths since 2003, for a CFR of 59%. Palese contended, as he has previously in other forums, that this ratio is too high, because only severe cases are being counted.”Only hospital cases are counted. People who are asymptomatically infected are not being counted,” he said. “The unfortunate WHO estimate is very high.”Flu researchers have sought to detect unreported and asymptomatic H5N1 cases by looking for H5N1 antibodies in the blood of people with potential past exposures to the virus. Palese said that in 10 studies with at least 500 subjects each, the infection rates ranged from 0.2% to 5.6%. If one assumes a 2% infection rate for people who are exposed to the virus but don’t have recognized cases, “the case-fatality with H5N1 really is much lower than what the WHO tries to say,” he asserted.Osterholm replied, “You can’t have your own facts, and you’ve been constantly putting your own facts on this.” He said that in 13 studies that met the WHO criteria for H5N1 serology, only 26 of 5,533 subjects were positive for H5N1 antibodies, for a rate of 0.469%.”But none of this is critical, because if this virus was 20 times less virulent than it is now, it would still be worse than [the] 1918 [pandemic flu virus],” he added. “The data are clear and compelling. It’d still be the worst flu pandemic in history.””I’m not saying anything other than what’s published in the literature,” replied Palese.Ferrets on trialParticipants also disagreed about the reliability of ferrets as models of flu effects in humans. Virologist Vincent Racaniello, PhD, a professor of microbiology and immunology at Columbia University’s College of Physicians and Surgeons, said that when he began studying viral pathogenesis under Albert Sabin and other eminent experts, “The first thing they said was when you study viruses in animals, don’t think you’ll learn much about what happens in humans.”Casadevall agreed that transmissibility in ferrets doesn’t necessarily predict transmissibility in humans, but he said it was “striking” that so many flu experts view ferrets as a suitable model for studying human flu.The NSABB contacted many flu experts from around the world, and with few exceptions, they said the ferret model “is a reasonable estimate of what might happen,” said Osterholm. Moreover, Fouchier himself, when he discussed his study at a European meeting last September, ended his talk saying, “‘This is now a very dangerous virus,'” Osterholm added.Laurie Garrett, PhD, senior fellow for global health at the Council on Foreign Relations, commented, “The public health asset argument is that these experiments provide predictive value to help public health and identify genetic changes that should be monitored. If the ferret is useless, with no predictive value, then I do not understand why the experiment was ever done.”Palese responded, “In fact the ferret is much too sensitive as an animal model, so I think an animal model is just that, an animal model, and not predictive.”In other exchanges about how dangerous the mutant H5N1 viruses might be, Osterholm contrasted H5N1 with smallpox.”I would not like to see smallpox get out of a BSL-4 [biosafety level 4, the highest level] lab, but it wouldn’t be overly concerning” in view of the vaccine and other countermeasures available, he said. He noted that the WHO had a quick-response plan to contain an incipient flu pandemic, but the 2009 pandemic showed its futility. “Once [flu] is out, it’s gone, it’s a worldwide issue,” he said.Palese responded, “I’m shocked to hear that you wouldn’t be concerned if smallpox got out. Two hundred million people died [of smallpox] in the 20th century, 500 for H5N1. H5N1 virus is so much less dangerous from what we know than smallpox.”Casadevall defended Osterholm’s position, commenting, “We have a smallpox vaccine, and there’s a long period of incubation.” The last outbreak in Europe was stopped with a quick vaccination campaign, he added.Some of the discussion focused on the potential benefits of the H5N1 studies and full publication of the details. Garrett questioned the benefits, saying, “One of the other great arguments in favor of public health benefits is that they tell us what we should watch for in nature. . . . Nothing could be further from the truth. Most of the viral samples of H5 are fragmentary, and there’s no routine capacity, especially in developing countries.”In response to an assertion from Osterholm that both the risks and benefits of research must be carefully weighed, Racaniello said, “For much of science you can’t do a risk-benefit analysis. If you think you can, you’re wrong.” He pointed to the 1950s discovery of restriction enzymes used by E coli to cut up the genes of viruses. The discovery drew little notice at the time, but eventually it turned out to be a key to the biotechnology revolution, he said.Questions about governmental roleOn the question of the governmental role in regulating dual-use research, Garrett said basic notions about the purposes of government lead to a contradiction. One of the prime duties of government is to protect the public from perceived threats, she said.”If you define the threat as a natural pandemic, you could argue that government should promote this kind of research, because it can lead to defenses,” she said. “But if you define the threat as bioterrorism or biosecurity or lab leaks, then government has an absolute mandate to intervene to control that research.”If the question is difficult at the national level, it’s even more so at the international level, Garrett said. “If you go to the international level, we have only the International Health Regulations and the 2011 virus-sharing agreement” hammered out by the WHO, she said. “We have absolutely no consensus as to what is the appropriate role of international governing bodies.”Later she added that the controversy puts the WHO in a very difficult position, “because the whole debate over virus sharing and who should have access was arguably the most emotional that’s gone on at WHO in my lifetime.” She referred to the 2011 agreement on international sharing of influenza and other viruses, particularly those collected in developing countries. Indonesia and other countries had protested the sharing of viruses, arguing that drug companies used the isolates to make vaccines that were unaffordable for the source countries.Casadevall voiced concern about the overregulation of science, especially clinical research. “I have to write a 100-page animal [research] protocol to do something to help society, when you can walk into a Home Depot and find many ways to kill a mouse without any protocol,” he said. “With this system in place, you’re going to kill science.”On the question of publication versus secrecy, Jasny estimated that about 1,000 people have already seen Fouchier’s data, including 800 who attended the European meeting where he discussed it, plus government officials and editors.Osterholm and Casadevall said the NSABB hasn’t suggested that the details can be kept secret for long, but they argued that withholding them nonetheless has short-term value.”Everyone knows you can make a fertilizer bomb. But I don’t think they want you to have the exact specifications on how to make a fertilizer bomb,” said Casadevall.When Lipkin raised the issue of lab security and containment levels, the debate turned heated once again.Osterholm said significant lab leaks of infectious agents don’t happen often, but added, “We can’t un-ring a bell. One day maybe it’ll be shown that this can’t transmit to people, but if we’re wrong and we find it does end up being transmitted . . . it’ll be just like 9/11. I don’t understand why it’s not going to be put into BSL-4 until we understand what we’re doing.”Palese, who had said earlier that the type of research in question is already very restricted, reiterated his argument that all the existing evidence does not suggest the mutant H5N1 would spread among humans.”There are many reasonable scientists who disagree with you,” Osterholm replied. Referring to the Sep 11 attacks, he added, “Damn it, this is a real possibility, and if we are wrong, the consequences could be so catastrophic that we’ll all go back and ask ourselves why did we let it happen.”Garrett warned that the debate over the research needs to include representatives of the general public, not just scientists. If an upcoming conference being planned by the WHO leads to some sort of agreement based only on discussion among scientists, she said, “It’s all going to backfire. It’s going to explode in our face.”The WHO has scheduled the conference for Feb 16 and 17, but the agenda and participants are still being firmed up, spokesman Gregory Hartl told CIDRAP News today.The value of a gutted paperIn response to question from Lipkin, Veronique Kiermer, PhD, executive editor of Nature, said the two H5N1 studies are worth publishing even if the details must be left out.”I think these two papers are very important and the overall message needs to be published,” she said. “Also the scientists who have done this work deserve to have credit.”She added that it will be important for any mechanism for disseminating the details to be fair, so that anyone with a real need to know can get the data. But how to define who those people are remains to be worked out, she acknowledged.Jasny commended the authors of the two H5N1 studies for being very responsible. “They could’ve withdrawn the papers and published them elsewhere if they so chose. They’re tried to work through the system, realizing the problems that are inherent in the situation. That’s another reason to publish a redacted manuscript, because they’ve played fair.”See also: Information on Feb 2 NYAS symposium on H5N1 dual use researchFeb 7 pre-debate interviews from Nature with panel membersList of panelistsDec 23, 2011, CIDRAP News story “Fears about mutant H5N1 hinge on ferrets as flu model”last_img read more

Auto Care Association Names Director Of Technology

first_imgFatmi specializes in project management, with the capacity to effectively manage, develop and deploy a large number of concurrent technology projects, including real-time, web-based and data-management systems at a corporate level. Fatmi’s expertise will be used to lead and manage the association’s technology team toward high collaboration and performance, and ensure responsive audits, design, and the development of tools and resources from point of concept through implementation. Fatmi holds an MBA and a master’s degree of science in Engineering Management/Software Engineering and Information Systems Management from George Washington University, and holds certifications in Salesforce and CSM (Certified Scrum Master). During his time at AARP (American Association for Retired Persons) as the Technology Project Leader, Fatmi successfully managed and delivered projects involving Microsoft SharePoint technologies, Microsoft CRM and other web technologies. Fatmi ensured timely updates and enhancements for new functionality and new solutions, and provided technical research, analyses, strategies and solutions to management for multiple projects. Fatmi also has led IT and technology departments at a number of other organizations throughout his career, including the AACC (American Association for Clinical Chemistry), SourceHOV, AHIP (America’s Health Insurance Plans) and ARA (American Retirement Association). The Auto Care Association has announced the addition of Shehryar Fatmi as director, technology, under its technology and standards department. Fatmi brings nearly two decades of experience in IT operations, project management, IT enterprise management and strategic planning. As Director of Technology, Fatmi will be responsible for the oversight and growth of all aspects of the Auto Care Association’s technology systems, tools, resources and data, including external-facing platforms and content.AdvertisementClick Here to Read MoreAdvertisementcenter_img For more information about the Auto Care Association’s technology projects and initiatives, visit autocare.org/technology. “We are very excited about the addition of Shehryar to the association’s technology team,” said Taylor Mitchell, senior vice president, technology, Auto Care Association. “Auto Care continues to invest in technology, both systems and people, and Shehryar’s proven track record of managing highly complex technology projects will help support our strategic, financial and larger organizational priorities and ultimate success.”Advertisementlast_img read more

One dead – more injured in Singapore fire

first_imgSubscribe Get instant access to must-read content today!To access hundreds of features, subscribe today! At a time when the world is forced to go digital more than ever before just to stay connected, discover the in-depth content our subscribers receive every month by subscribing to gasworld.Don’t just stay connected, stay at the forefront – join gasworld and become a subscriber to access all of our must-read content online from just $270.last_img

Den Oever Dike Reinforcement Contract for Van Oord

first_imgHollands Noorderkwartier Regional Water Board (HHNK) has awarded the dike reinforcement project Den Oever in the north of the Netherlands to Van Oord. The work is set to begin in 2017 and will continue until 2019, Van Ord said in the announcement.The project, part of the Dutch Flood Protection Program, will encompass the design and the reinforcement of 900 meters of dike.After completion the dike meets the legal standard of 1:4,000. This means that the dike has to withstand a superstorm that occurs on average once in 4,000 years.The project was awarded to Van Oord because of the attention that will be given to the surrounding community during the execution of the project.Kees Stam, Hollands Noorderkwartier Regional Water Board, said: “I am delighted that after years of thorough preparation Van Oord is going to realize the project for us.”Van Oord plans to deploy crane vessels, barges and dry earth moving equipment for this project.[mappress mapid=”23110″]last_img read more

A cable to the sun

first_imgSubscribe now for unlimited access Get your free guest access  SIGN UP TODAY Subscribe to Building today and you will benefit from:Unlimited access to all stories including expert analysis and comment from industry leadersOur league tables, cost models and economics dataOur online archive of over 10,000 articlesBuilding magazine digital editionsBuilding magazine print editionsPrinted/digital supplementsSubscribe now for unlimited access.View our subscription options and join our community Stay at the forefront of thought leadership with news and analysis from award-winning journalists. Enjoy company features, CEO interviews, architectural reviews, technical project know-how and the latest innovations.Limited access to building.co.ukBreaking industry news as it happensBreaking, daily and weekly e-newsletters To continue enjoying Building.co.uk, sign up for free guest accessExisting subscriber? LOGINlast_img read more